Brokerage Reports | Latest & Breaking News on Brokerage Reports | Photos, Videos, Breaking Stories and Articles on Brokerage Reports

ALL
News
Opinion
Photos
Videos

Jump to

Buy Venus Remedies; target Rs 350: Sunidhi Securities

Sunidhi Securities is bullish on Venus Remedies (VRL) and has recommended buy rating on the stock with a price target of Rs 350 in its July 15, 2013 research report.
Buy Venus Remedies; target of Rs 400: Sunidhi Securities

Sunidhi Securities is bullish on Venus Remedies and has recommended buy rating on the stock with a target of Rs 400 in its October 3, 2012 research report.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347

Buy Venus Remedies; target Rs 350: Sunidhi Securities

Buy Venus Remedies; target of Rs 400: Sunidhi Securities